Developing the Next Generation of COVID-19 Vaccines - amfAR, The Foundation for AIDS Research

Researchers have again parlayed HIV research to COVID-19 to develop a nanoparticle mRNA-based vaccine platform to address SARS-CoV-2 variants.

Research questionUse of mRNA technology by two drug companies, Pfizer and Moderna, in the design of vaccines against SARS-CoV-2, the virus that causes COVID-19, revolutionized the response to this in… [+1438 chars]

full article...